![Stephen Dilly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Dilly
Presidente presso
CODEXIS, INC.
Patrimonio netto: 1 M $ in data 30/09/2026
Profilo
Dr. Stephen G.
Dilly is a President, Chief Executive Officer & Director at Sonoma Biotherapeutics, Inc. and an Executive Chairman at Codexis, Inc. He is on the Board of Directors at Sonoma Biotherapeutics, Inc., Aurimi Therapeutics, Inc. and Adjuvance Technologies, Inc. Dr. Dilly was previously employed as a President, Chief Executive Officer & Director by Sierra Oncology, Inc., an Executive Chairman by DNAtrix, Inc., a President, Chief Executive Officer & Director by Aimmune Therapeutics, Inc., a President, Chief Executive Officer & Director by PhotoThera, Inc., an Independent Director by Sangamo Therapeutics, Inc., a President, Chief Executive Officer & Director by APT Pharmaceuticals, Inc., a Chief Medical Officer & SVP-Development by CHIRON Biopharmaceuticals, a Vice President-Development Sciences by Genentech, Inc., a Chairman by Cognoa, Inc., and an Advisor by Physic Ventures LLC.
He also served on the board at Avigen, Inc. He received his doctorate degree from the University of London and a doctorate degree from the University of London.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CODEXIS, INC. 0,66% | 17/06/2026 | 727.053 ( 0,66% ) | 1 M $ | 30/09/2026 |
Posizioni attive di Stephen Dilly
| Società | Posizione | Inizio |
|---|---|---|
| CODEXIS, INC. | Presidente | - |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Direttore/Membro del Consiglio | 07/02/2020 |
Adjuvance Technologies, Inc.
 Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Direttore/Membro del Consiglio | - |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing of cell and genetic therapies for autoimmune & degenerative diseases | Amministratore Delegato | 17/11/2025 |
Precedenti posizioni note di Stephen Dilly
| Società | Posizione | Fine |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Amministratore Delegato | 01/07/2022 |
| SANGAMO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 30/09/2020 |
| AIMMUNE THERAPEUTICS, INC. | Amministratore Delegato | 19/06/2018 |
PhotoThera, Inc.
 PhotoThera, Inc. Medical SpecialtiesHealth Technology Develops and distributes infrared therapeutic devices | Amministratore Delegato | 01/12/2012 |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Amministratore Delegato | 01/12/2011 |
Formazione di Stephen Dilly
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
88
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
PhotoThera, Inc.
PhotoThera, Inc. Medical SpecialtiesHealth Technology Develops and distributes infrared therapeutic devices | Health Technology |
APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physic Ventures LLC
 Physic Ventures LLC Investment ManagersFinance Physic Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
CHIRON Biopharmaceuticals | |
Adjuvance Technologies, Inc.
Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Offers a mobile app and proprietary algorithm to enable early detection of autism | Health Services |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing of cell and genetic therapies for autoimmune & degenerative diseases | Health Technology |
